![Peter Collins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Collins
Geen lopende functies
Vermogen: 101 200 $ op 30-06-2026
Profiel
Peter Michael Collins is the founder of European Personalised Medicine Association.
Former jobs include Chief Executive Officer at SAGA Diagnostics AB, Chief Executive Officer & Director at CelLBxHealth Plc, Director & Chief Commercial Officer at Yourgene Health Ltd., Vice President & Head-Diagnostics at GSK Plc, Principal at Riverside Biosciences Ltd., Principal at BioGenex Laboratories, Inc., Principal at Gentronix Ltd., Principal at Pronostics Ltd., Senior Vice President-Pharma Business Development at DxS Ltd., Vice President-Marketing & Sales at Abbott Molecular Diagnostics, and Vice President-Pharma Business Development at QIAGEN Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CELLBXHEALTH PLC 0,44% | 18-12-2025 | 5.000.000 ( 0,44% ) | 101 200 $ | 30-06-2026 |
Eerdere bekende functies van Peter Collins
| Bedrijven | Functie | Einde |
|---|---|---|
| CELLBXHEALTH PLC | Algemeen Directeur | 06-07-2026 |
| YOURGENE HEALTH | Directeur/Bestuurslid | 01-11-2018 |
SAGA Diagnostics AB
 SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Algemeen Directeur | - |
| GSK PLC | Corporate Officer/Principal | - |
Qiagen Ltd.
 Qiagen Ltd. Medical/Nursing ServicesHealth Services Engages in other human health activities | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
CelLBxHealth Plc
 CelLBxHealth Plc Medical DistributorsDistribution Services Operates as a holding company with interests in providing products in cancer diagnostics and foetal health | Distribution Services |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Riverside Biosciences Ltd.
 Riverside Biosciences Ltd. Medical SpecialtiesHealth Technology Produces neo natal blood testing kits | Health Technology |
BioGenex Laboratories, Inc.
 BioGenex Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Provides solutions for automation of cell and tissue testing | Health Technology |
Gentronix Ltd.
 Gentronix Ltd. BiotechnologyHealth Technology Provides services and solutions to help organizations optimize the development of drugs and other chemicals | Health Technology |
Pronostics Ltd.
 Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Provides and develops diagnostic test for heart disease | Health Technology |
DxS Ltd.
 DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Health Technology |
Abbott Molecular Diagnostics | |
Qiagen Ltd.
Qiagen Ltd. Medical/Nursing ServicesHealth Services Engages in other human health activities | Health Services |
European Personalised Medicine Association | |
Yourgene Health Plc
 Yourgene Health Plc Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
SAGA Diagnostics AB
SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Health Technology |
Kies MarketScreener 
